Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Christopher DeGroat"'
Autor:
Jung Rae Cho, Zeina Alobaidi, Francesco Franchi, Martin M. Zenni, Mona Bhatti, Elisabetta Ferrante, Theodore A. Bass, Atsuhiro Sugidachi, Christopher DeGroat, Dominick J. Angiolillo, Lydia R. Engwenyu, Joseph A. Jakubowski, Fabiana Rollini
Publikováno v:
Thrombosis and Haemostasis. 117:201-203
Impact of chronic kidney disease on platelet P2Y12 receptor signalling in patients with type 2 diabetes mellitus
Autor:
Mona Bhatti, Jung Rae Cho, Luis A. Guzman, Theodore A. Bass, Dominick J. Angiolillo, Edward Carraway, Fabiana Rollini, Siva Suryadevara, Martin M. Zenni, Francesco Franchi, Christopher DeGroat, Amit Nanavati, Elisabetta Ferrante, Elizabeth C Dunn
Publikováno v:
JACC: Cardiovascular Interventions. 8:1457-1467
Objectives The goal of this study was to assess the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of escalating ticagrelor loading dose (LD) regimens in primary percutaneous coronary intervention (PPCI). Background Patients with ST-segment e
Autor:
Jung Rae Cho, Francesco Franchi, Fabiana Rollini, Martin M. Zenni, Ronakkumar Patel, Antonio Tello-Montoliu, Dominick J. Angiolillo, Jose-Luis Ferreiro, Bhaloo Desai, Luis A. Guzman, Theodore A. Bass, Andrew Darlington, Ana Muniz-Lozano, Elisabetta Ferrante, Mona Bhatti, Christopher DeGroat
Publikováno v:
Journal of Cardiovascular Translational Research. 7:53-63
Smokers have a greater relative benefit of clopidogrel therapy compared with nonsmokers, likely attributed to its enhanced pharmacodynamic (PD) effects. However, to date, all PD studies have been conducted in patients on dual antiplatelet therapy wit
Publikováno v:
Journal of the American College of Cardiology. 73:2773
Patients born with congenital heart defects can present later in life with very unique problems. This report describes one such patient. A 38 year-old man with an unknown congenital heart defect presented to an outside hospital with chest pain. He wa
Autor:
Lydia R, Engwenyu, Francesco, Franchi, Fabiana, Rollini, Jung Rae, Cho, Christopher, DeGroat, Mona, Bhatti, Zeina, Alobaidi, Elisabetta, Ferrante, Joseph A, Jakubowski, Atsuhiro, Sugidachi, Martin, Zenni, Theodore A, Bass, Dominick J, Angiolillo
Publikováno v:
Thrombosis and haemostasis. 117(1)
Autor:
Fabiana, Rollini, Francesco, Franchi, Kamaldeep, Singh, Jung Rae, Cho, Mona, Bhatti, Christopher, DeGroat, Jenny, Hu, Niti, Aggarwal, Zeina, Alobaidi, Estela, Thano, Elisabetta, Ferrante, Martin, Zenni, Theodore A, Bass, Dominick J, Angiolillo
Publikováno v:
Thrombosis and haemostasis. 116(6)
Several platelet function tests (PFT) are available to assess the pharmacodynamic (PD) effects of P2Y
Autor:
Kamaldeep Singh, Elizabeth C Dunn, Jung Rae Cho, Mona Bhatti, Theodore A. Bass, Martin M. Zenni, Elisabetta Ferrante, Luis A. Guzman, Ana Muniz-Lozano, Christopher DeGroat, Francesco Franchi, Ryan E. Wilson, Dominick J. Angiolillo, Fabiana Rollini
Publikováno v:
European heart journal. 37(35)
Pharmacodynamic (PD) studies comparing prasugrel and ticagrelor have reached inconsistent findings. Therefore, a comprehensive investigation comparing the PD effects of prasugrel vs. ticagrelor after switching from clopidogrel therapy, exploring both
Autor:
Theodore A. Bass, Francesco Franchi, Fladia Phoenix, Martin M. Zenni, Christopher DeGroat, Ramzi A. Ajjan, Jung Rae Cho, Fabiana Rollini, Rhodri King, Dominick J. Angiolillo, Mona Bhatti, Luis A. Guzman, Antonio Tello-Montoliu
Publikováno v:
Thrombosis and haemostasis. 115(3)
SummaryThere is growing interest in understanding the effects of adding an oral anticoagulant in patients on dual antiplatelet therapy (DAPT). Vitamin K antagonists (VKAs) and clopidogrel represent the most broadly utilised oral anticoagulant and P2Y
Autor:
Francesco, Franchi, Fabiana, Rollini, Jung Rae, Cho, Mona, Bhatti, Christopher, DeGroat, Elisabetta, Ferrante, Elizabeth C, Dunn, Amit, Nanavati, Edward, Carraway, Siva, Suryadevara, Martin M, Zenni, Luis A, Guzman, Theodore A, Bass, Dominick J, Angiolillo
Publikováno v:
JACC. Cardiovascular interventions. 8(11)
The goal of this study was to assess the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of escalating ticagrelor loading dose (LD) regimens in primary percutaneous coronary intervention (PPCI).Patients with ST-segment elevation myocardial inf
Autor:
Jung Rae, Cho, Fabiana, Rollini, Francesco, Franchi, Christopher, DeGroat, Mona, Bhatti, Elizabeth C, Dunn, Elisabetta, Ferrante, Ana, Muniz-Lozano, Siva, Suryadevara, Martin M, Zenni, Luis A, Guzman, Theodore A, Bass, Dominick J, Angiolillo
Publikováno v:
JACC. Cardiovascular interventions. 8(8)
The aim of this study was to assess the impact of ticagrelor dosing regimens on pharmacodynamic (PD) profiles in patients on maintenance ticagrelor therapy.Many patients on maintenance P2Y12-inhibiting therapies may require coronary revascularization